Capha Pharmaceuticals Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was CAD 0.017104 million compared to CAD 0.019468 million a year ago. For the nine months, net loss was CAD 0.041319 million compared to CAD 0.050087 million a year ago.